11. Glypican‐3 antibodies: A new therapeutic target for liver cancer. Issue 2 (15th October 2013) Authors: Feng, Mingqian; Ho, Mitchell Journal: FEBS letters Issue: Volume 588:Issue 2(2014) Page Start: 377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Highlights of 2019 Protein Engineering Summit (PEGS) in Boston, USA: advancing antibody-based cancer therapies to the clinic. (3rd December 2019) Authors: Li, Hong; Li, You; Wang, Cheng; Wang, Shouye; Ho, Mitchell Journal: Antibody therapeutics Issue: Volume 2:Number 4(2019) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Highlights of Antibody Engineering and Therapeutics 2019 in San Diego, USA: Bispecific Antibody Design and Clinical Applications. (6th June 2020) Authors: Zhu, Yong; Shen, Run; Hao, Rui; Wang, Shouye; Ho, Mitchell Journal: Antibody therapeutics Issue: Volume 3:Number 2(2020) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Humanization of rabbit monoclonal antibodies via grafting combined Kabat/IMGT/Paratome complementarity-determining regions: Rationale and examples. Issue 3 (3rd April 2017) Authors: Zhang, Yi-Fan; Ho, Mitchell Journal: MAbs Issue: Volume 9:Issue 3(2017) Page Start: 419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Humanization of the Shark VNAR Single Domain Antibody Using CDR Grafting. Issue 1 (3rd January 2023) Authors: Zhang, Yi‐Fan; Sun, Yaping; Hong, Jessica; Ho, Mitchell Journal: Current protocols Issue: Volume 3:Issue 1(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican‐3 for liver cancer therapy. Issue 2 (18th June 2014) Authors: Gao, Wei; Kim, Heungnam; Feng, Mingqian; Phung, Yen; Xavier, Charles P.; Rubin, Jeffrey S.; Ho, Mitchell Journal: Hepatology Issue: Volume 60:Issue 2(2014:Aug.) Page Start: 576 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Inaugural Editorial: Searching for Magic Bullets. (20th June 2018) Authors: Ho, Mitchell Journal: Antibody therapeutics Issue: Volume 1:Number 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Isolation of Antibodies to Heparan Sulfate on Glypicans by Phage Display. (9th August 2018) Authors: Kim, Heungnam; Ho, Mitchell Editors: Coligan, John E.; Dunn, Ben M.; Speicher, David W.; Wingfield, Paul T. Journal: Current protocols in protein science Issue: Volume 94(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Isolation of rabbit single domain antibodies to B7-H3 via protein immunization and phage display. (17th February 2020) Authors: Feng, Ruonan; Wang, Ruixue; Hong, Jessica; Dower, Christopher M; Croix, Brad St; Ho, Mitchell Journal: Antibody therapeutics Issue: Volume 3:Number 1(2020) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Melanoma-associated B cells are distinct from peripheral blood-derived B cells, and may serve as a source of tumor-targeting antibodies. (7th November 2013) Authors: Abate-Daga, Daniel; Alexander, Theresa A; Arons, Evgeny; Ho, Mitchell; Robbins, Paul F; Rosenberg, Steven A; Morgan, Richard A Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗